HealthLynked Corp. (HLYK) Stock

About HealthLynked Corp.

HealthLynked Corporation operates a digital platform in the United States for the management and archiving of patient information, utilizing cloud technology. The company's business activities are organized into four main segments: Health Services, Digital HealthCare, Accountable Care Organization/Managed Service Organization (ACO/MSO), and Medical Distribution. The Health Services division offers specialized medical care, including obstetrics and gynecology, and provides functional medicine services with a focus on neurodegenerative conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. This segment also includes "Bridging the Gap Physical Therapy," a practice dedicated to enhancing patient recovery and managing pain without reliance on medication or surgery. The Digital HealthCare division oversees the HealthLynked Network, an online cloud-based system that enables both patients and doctors to monitor medical records. Patients can also input comprehensive personal health details, covering past surgeries, medications, allergies, and family medical histories. Additionally, this division provides an online functionality for patients to schedule appointments with healthcare providers. The ACO/MSO division manages an Accountable Care Organization and a Management Service Organization. These entities assist physician practices in delivering patient care, particularly through the Medicare Shared Savings Program, and offer professional consulting services to other healthcare providers and ACOs under contractual agreements. The Medical Distribution division functions as an online distributor, supplying discounted medical products directly to individual consumers and medical practices. HealthLynked was founded in 2014 and its corporate headquarters are located in Naples, Florida.

HealthLynked Corp. is headquartered in US.

HealthLynked Corp. (HLYK) stock trades at $2.70 with a market capitalization of $7.94M. The stock is valued at a price-to-earnings (P/E) ratio of -2.00, price-to-book of -1.12, price-to-sales of 4.63. Over the past 52 weeks the stock has ranged between $1.06 and $6.50, and currently trades 58.5% below its 52-week high.

On profitability, HealthLynked Corp. generates a return on equity (ROE) of 67.06% — well above the market average, a sign of a high-quality business, return on capital employed of 33.43%, an operating margin of -128.12%, a net profit margin of -224.58%.

Official website: www.healthlynked.com